This blog was written by Kelly Church, Managing Associate at IMC Worldwide, with contributions from Stacy Knobler, Senior Director at the Sabin Vaccine Institute. The below posting is a promotion for the COVIDaction Vaccine Data Co-Lab Event, hosted on April 15th, and looks to outline PriorityVax, a multi-criteria decision analysis tool that aids the evaluation process for priority setting, as well as highlight the Boost Community. Below is an expert from this blog post - the full post can be found on the COVIDaction Medium page. 

Several effective vaccines — with more to come — promise to relieve the humanitarian and economic crises brought on by COVID-19. While demand for such vaccines outstrips supply, equitable access must be ensured. The PriorityVax decision-support platform provides a customizable, web-based tool in which users can employ the national and subnational data they have identified as best-suited to inform their priority-setting decisions and to place equity at the center of vaccine selection, allocation, and distribution.

The platform’s priority-setting analyses can easily be adapted to support a range of established frameworks for COVID-19 vaccine allocation and data generation. Analytical templates have been developed to support both the WHO and NASEM equitable allocation frameworks and the use of model-generated data from sources such as the Africa COVID Community Vulnerability Index. Importantly, these same analyses can account for additional considerations specific to national-, district- and community-level decision-makers and stakeholders. A brief demonstration of these analyses and how the tool works will be shared during the COVIDAction Vaccine Data Co-Lab event.

To continue reading about Priority Vax...

Click here!